204 related articles for article (PubMed ID: 9661885)
1. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter.
Lee K; Belinsky MG; Bell DW; Testa JR; Kruh GD
Cancer Res; 1998 Jul; 58(13):2741-7. PubMed ID: 9661885
[TBL] [Abstract][Full Text] [Related]
2. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins.
Belinsky MG; Bain LJ; Balsara BB; Testa JR; Kruh GD
J Natl Cancer Inst; 1998 Nov; 90(22):1735-41. PubMed ID: 9827529
[TBL] [Abstract][Full Text] [Related]
3. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver.
Belinsky MG; Kruh GD
Br J Cancer; 1999 Jul; 80(9):1342-9. PubMed ID: 10424734
[TBL] [Abstract][Full Text] [Related]
4. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.
Taniguchi K; Wada M; Kohno K; Nakamura T; Kawabe T; Kawakami M; Kagotani K; Okumura K; Akiyama S; Kuwano M
Cancer Res; 1996 Sep; 56(18):4124-9. PubMed ID: 8797578
[TBL] [Abstract][Full Text] [Related]
5. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
[TBL] [Abstract][Full Text] [Related]
6. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.
Narasaki F; Oka M; Nakano R; Ikeda K; Fukuda M; Nakamura T; Soda H; Nakagawa M; Kuwano M; Kohno S
Biochem Biophys Res Commun; 1997 Nov; 240(3):606-11. PubMed ID: 9398612
[TBL] [Abstract][Full Text] [Related]
7. Regulation of organic anion transport in the liver.
Roelofsen H; Müller M; Jansen PL
Yale J Biol Med; 1997; 70(4):435-45. PubMed ID: 9626764
[TBL] [Abstract][Full Text] [Related]
8. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.
Paulusma CC; van Geer MA; Evers R; Heijn M; Ottenhoff R; Borst P; Oude Elferink RP
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):393-401. PubMed ID: 10024515
[TBL] [Abstract][Full Text] [Related]
9. [Hepatic metabolism and transport of bilirubin and other organic anions].
Adachi Y; Kamisako T; Okuyama Y; Miya H
Nihon Rinsho; 1996 Aug; 54(8):2276-90. PubMed ID: 8810807
[TBL] [Abstract][Full Text] [Related]
10. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
Borst P; Kool M; Evers R
Semin Cancer Biol; 1997 Jun; 8(3):205-13. PubMed ID: 9441949
[TBL] [Abstract][Full Text] [Related]
11. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.
Evers R; Kool M; van Deemter L; Janssen H; Calafat J; Oomen LC; Paulusma CC; Oude Elferink RP; Baas F; Schinkel AH; Borst P
J Clin Invest; 1998 Apr; 101(7):1310-9. PubMed ID: 9525973
[TBL] [Abstract][Full Text] [Related]
12. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver.
Wielandt AM; Vollrath V; Manzano M; Miranda S; Accatino L; Chianale J
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):105-11. PubMed ID: 10377250
[TBL] [Abstract][Full Text] [Related]
13. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents.
Zeng H; Bain LJ; Belinsky MG; Kruh GD
Cancer Res; 1999 Dec; 59(23):5964-7. PubMed ID: 10606242
[TBL] [Abstract][Full Text] [Related]
14. Participation of the multispecific organic anion transporter in hepatobiliary excretion of glutathione S-conjugates, drugs and other xenobiotics.
Makowski P; Pikuła S
Pol J Pharmacol; 1997; 49(6):387-94. PubMed ID: 9566041
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of xenobiotic detoxification system mediated by efflux transporters].
Suzuki H
Yakugaku Zasshi; 1999 Nov; 119(11):822-34. PubMed ID: 10590710
[TBL] [Abstract][Full Text] [Related]
16. Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes.
Roelofsen H; Bakker CT; Schoemaker B; Heijn M; Jansen PL; Elferink RP
Hepatology; 1995 Jun; 21(6):1649-57. PubMed ID: 7768511
[TBL] [Abstract][Full Text] [Related]
17. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.
Hirohashi T; Suzuki H; Ito K; Ogawa K; Kume K; Shimizu T; Sugiyama Y
Mol Pharmacol; 1998 Jun; 53(6):1068-75. PubMed ID: 9614210
[TBL] [Abstract][Full Text] [Related]
18. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome.
Paulusma CC; Kool M; Bosma PJ; Scheffer GL; ter Borg F; Scheper RJ; Tytgat GN; Borst P; Baas F; Oude Elferink RP
Hepatology; 1997 Jun; 25(6):1539-42. PubMed ID: 9185779
[TBL] [Abstract][Full Text] [Related]
19. The function of the multidrug resistance proteins (MRP and cMRP) in drug conjugate transport and hepatobiliary excretion.
Keppler D; Leier I; Jedlitschky G; Mayer R; Büchler M
Adv Enzyme Regul; 1996; 36():17-29. PubMed ID: 8869738
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell.
Almquist KC; Loe DW; Hipfner DR; Mackie JE; Cole SP; Deeley RG
Cancer Res; 1995 Jan; 55(1):102-10. PubMed ID: 7805019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
